Goldman Sachs’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Sell |
502,169
-105,615
| -17% | -$77.4K | ﹤0.01% | 4423 |
|
|
2025
Q1 | $608K | Sell |
607,784
-33,139
| -5% | -$33.1K | ﹤0.01% | 4147 |
|
|
2024
Q4 | $6.79M | Buy |
640,923
+300,902
| +88% | +$3.19M | ﹤0.01% | 2622 |
|
|
2024
Q3 | $4.49M | Buy |
340,021
+21,564
| +7% | +$285K | ﹤0.01% | 2834 |
|
|
2024
Q2 | $3.13M | Buy |
318,457
+155,878
| +96% | +$1.53M | ﹤0.01% | 2935 |
|
|
2024
Q1 | $2.24M | Sell |
162,579
-429,843
| -73% | -$5.91M | ﹤0.01% | 3142 |
|
|
2023
Q4 | $10.1M | Buy |
592,422
+518,822
| +705% | +$8.85M | ﹤0.01% | 2074 |
|
|
2023
Q3 | $1.04M | Buy |
+73,600
| New | +$1.04M | ﹤0.01% | 3514 |
|